BRIEF-CSPC Pharmaceutical Says CSPC Innovation Pharmaceutical HY Net Profit Attributable Was RMB155.1 Mln

Reuters2021-08-19

Aug 19 (Reuters) - CSPC Pharmaceutical Group Ltd :

* CSPC INNOVATION PHARMACEUTICAL HY NET PROFIT ATTRIBUTABLE RMB155.1 MILLION VERSUS RMB152.9 MILLION

* HY REVENUE OF CSPC INNOVATION PHARMA RMB 707.4 MILLION VERSUS RMB 687.2 MILLION

Source text for Eikon: Further company coverage:

(Reuters.Briefs@thomsonreuters.com)

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法